In: Commentaries

The strategy may change, but high quality standards should stay
July 9, 2018

Like many of our colleagues in neuroscience, we were surprised to see the recent steps Pfizer took in the field of…

Read More
Is reading book summaries the same as reading the actual book?
June 6, 2018

Books that can be summarized in three sentences (https://jamesclear.com/book-summaries). And one can summarize in a couple of sentences what most movies…

Read More
How to grow a healthy lab
June 6, 2018

A healthy research environment is fundamental to good science. However, this is an aspect that is rarely discussed. That’s partly because…

Read More
How to shift the incentive for researchers from quantity to quality?
June 6, 2018

In the current hyper-competitive research environment, scientists feel the constant need to publish novel findings as often and as fast as…

Read More
Crossing the river
March 30, 2018

In the previous issue of the Newsletter, we have already highlighted the recent paper by Bernhard Voelkl et al. from University…

Read More
Everyone knows mouse research is completely pointless
March 30, 2018

We strongly disagree with the title above – however, this statement is borrowed from a recent post on Medical Republic. While…

Read More
‘Don’t shoot the dog!’
February 27, 2018

Behavioral scientists know very well how to train humans and animals to perform a desired response and how to avoid behaviors…

Read More
Lessons from clinical studies’ (Martin C. Michel)
January 23, 2018

At least partly driven by regulatory requirements, technical data quality in clinical studies has markedly improved in the past decades and…

Read More
The link between Portfolio Evolution and the Robustness of early phase drug discovery data
December 19, 2017

The reproducibility discussion involves everyone who funds, authorizes, supervises, plans, conducts and publishes research. This recent LifeSciVC post showed that lacking research rigor…

Read More
The link between Portfolio Evolution and the Robustness of early phase drug discovery data
December 19, 2017

The reproducibility discussion involves everyone who funds, authorizes, supervises, plans, conducts and publishes research. This recent LifeSciVC post showed that lacking…

Read More